Capstone director Michael Toporek acquires common shares worth $167,000

PUBT · 3d ago
Capstone director Michael Toporek acquires common shares worth $167,000
  • Capstone Therapeutics director Michael Toporek bought 41,750 common shares in an open-market purchase at USD 4 per share.
  • Toporek’s direct stake rose to 41,750 shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-024417), on July 24, 2026, and is solely responsible for the information contained therein.